Cytomegalovirus (CMV) infection sometimes causes large expansions of CMV-specific T cells, particularly in older people. This is believed to undermine immunity to other pathogens and to accelerate immunosenescence. While multiple different CMV proteins are recognized, most publications on age-related T-cell expansions have focused on dominant target proteins UL83 or UL123, and the T-cell activation marker interferon-γ (IFN-γ). We were concerned that this narrow approach might have skewed our understanding of CMV-specific immunity at older ages. We have, therefore, widened the scope of analysis to include in vitro-induced T-cell responses to 19 frequently recognized CMV proteins in "young" and "older" healthy volunteers and a group of "oldest old" long-term survivors (>85 years of age). Polychromatic flow cytometry was used to analyze T-cell activation markers (CD107, CD154, interleukin-2 [IL-2], tumor necrosis factor [TNF], and IFN-γ) and memory phenotypes (CD27, CD45RA). The older group had, on average, larger T-cell responses than the young, but, interestingly, response size differences were relatively smaller when all activation markers were considered rather than IFN-γ or TNF alone. The oldest old group recognized more proteins on average than the other groups, and had even bigger T-cell responses than the older group with a significantly larger central memory CD4 T-cell component.
T cells have a central role in containing virus infections, and T-cell immunity to cytomegalovirus (CMV) has been repeatedly characterized [1] [2] [3] [4] . As aged T cells die, the thymus gland replenishes the T-cell pool with fresh, naive cells, but thymic output is reduced by 90% in 20-year-olds, and by 99% in 70-year-olds, compared to newborns [5] . However, T-cell numbers do not decline significantly as we age because memory T-cell proliferation compensates for the lack of fresh naive cells.
CMV infection is uniquely effective in driving compensatory memory T-cell proliferation; other herpes viruses have been implicated in this process to a much lesser degree [6, 7] . Frequent reactivation of latent CMV is thought to repetitively stimulate the T-cell compartment, driving up its size over time [8] . Very large CMV-specific T-cell responses observed in older people have created the paradigm of CMV-induced T-cell "memory inflation" [9] . Some researchers suspect that these T-cell expansions undermine immune responsiveness by skewing the T-cell receptor repertoire toward CMV [2, 10, 11] . However, the studies to date that explore the relationship between immunosenescence and the size of the CMV-specific T-cell response in humans have considered a limited number of recognized target proteins. By focusing on specific proteins, or even individual epitopes and single functions (eg, IFN-γ), they have created a fragmented picture of CMV-specific T-cell immunity in older life [10] [11] [12] [13] [14] [15] [16] .
We intended to assess whether CMV infection leads to a large increase of CMV-specific T cells in older people by measuring T-cell responsiveness to a wider, more representative range of proteins than previously studied, and also including several functional response readouts. We used protein-spanning peptide pools for CMV antigen-specific stimulation [17] [18] [19] [20] [21] [22] [23] . Target protein selection was based on our previous work showing that the full size of the response to CMV (represented by 213 protein-spanning peptide pools) can be extrapolated from the responses to 19 proteins, including 6 dominant CD4 and 15 dominant CD8 T-cell targets [24] .
The increase of T-cell response size was smaller in the CD8 but larger in the CD4 compartment in older compared to young participants than previously reported. In addition, our analysis of response breadth and T-cell memory compartments across all protein-specific responses provides new insight into the changes that occur in older people and a potential signature of successful aging.
METHODS

Ethics Statement
This study was approved by the UK National Research Ethics Service (NRES) (09/H1102/84) and the University of Parma Ethics Committee. Written informed consent was obtained from all participants. The study was conducted in agreement with the Declaration of Helsinki.
Participants
Fifty-five healthy volunteers referred to as "young" (19-35 years, including university students and staff ) and 131 healthy volunteers referred to as "older" (60-85 years, recruited by general medical practitioners) were recruited in Brighton (United Kingdom). Twenty-two additional individuals, referred to as "oldest old" (85-102 years) with known T-cell responsiveness to CMV were recruited at Parma University Hospital (Italy) as a comparison group of particularly advanced age. Exclusion criteria were designed to select generally healthy young and older individuals, but in the oldest old the presence of cerebrovascular and/or cardiovascular disease (heart failure, transient ischemic attack, acute myocardial infarction) was accepted, as this is representative of such an advanced age. Details of all inclusion/exclusion criteria and demographics for CMV participants are provided in the online Supplement. Demographics for CMV + participants are shown in Table 1 . Venous blood was collected in sodium-heparin plasma tubes (BD, Oxford, UK). Only CMV + individuals (52.6% of the older and 47.3% of the young participants) were selected for the analysis of CMV-specific T-cell responsiveness. The proportion of nonwhite among the young participants ranged from 20% to 33%, depending on the analysis. There were no statistically significant differences between white and nonwhite British participants with respect to response size distribution.
CMV Serology
CMV immunoglobulin G (IgG) serology (Architect CMV IgG, Abbot, Maidenhead, UK) was performed at the Brighton and Sussex University Hospital Trust virology laboratory.
Peripheral Blood Mononuclear Cell Isolation and Activation
Peripheral blood mononuclear cells (PBMCs) were isolated by density-gradient centrifugation (Ficoll-Hypaque, PLUS Healthcare, Buckinghamshire, UK) as described previously [25] . PBMCs were resuspended at 5 × 10 6 cells/mL in complete Roswell Park Memorial Institute medium (Fisher Scientific, Loughborough, UK) containing 10% fetal calf serum (Fisher). For each tube, 200 μL of PBMC suspension was incubated with peptide pools dissolved in dimethyl sulfoxide (SigmaAldrich, Gillingham, UK), dimethyl sulfoxide alone as a negative control, or staphylococcal enteroxin B (SEB, Sigma) as a positive control, and monensin (BD) for 2 hours in a standard incubator (37°C, humidified 5% CO 2 atmosphere) before the addition of brefeldin A (Sigma) for the remaining incubation time of 14 hours. More details are provided in the online Supplement.
CMV Peptide Pools
Peptides (15-amino-acid length, 11-amino-acid overlap between adjacent peptides) spanning the entire amino acid sequence of 19 CMV proteins were prepared by solid-phase synthesis using the same protein sequences as previously published [24] . Quality control included mass spectroscopy and high-performance liquid chromatography. Peptide purity was generally >80%. One peptide pool per protein was generated (Pepmix, JPT Peptide Technologies, Berlin, Germany) save for UL48, for which 2 pools were required. Pools were arranged in 16 stimulation pools, of which 12 contained 1 protein (frequent responses) and 4 contained 2 proteins each (as they elicited less frequent responses) ( Table 2 ). Freeze-dried pools were stored at -80°C. 
Antibodies and Cell Staining
We used the following fluorescence-conjugated monoclonal antibodies; anti-CD3-v500, anti-CD8-allophycocyanin(AP-C)-H7, anti-CD27-phycoerythrin(PE), IL-2-fluorescein isothiocyanate(FITC), TNF-α-Alexa 700, CD107a-APC (all BD Biosciences, Oxford, UK), anti-CD4-peridinin chlorophyll(PerCP), anti-IFN-γ PE-cyanine 7(Cy7), anti-CD154 pacific-blue (BioLegend, Cambridge, UK), anti-CD45RA-phycoerythrin-Texas Red(ECD) (Beckman Coulter, UK), and yellow live-dead stain (Invitrogen, Paisley, UK). Cells were stained on the surface and intracellularly as described previously [25] (see online Supplement for details).
Data Analysis and Gating Strategy
FlowJo v9.x software (Tree Star Inc, Ashland, OR) was used for analysis. After identifying CD4 and CD8 T cells, individual gates were set on activation marker-positive events (Supplementary Figure S1 ) and then combined using the FlowJo Boolean gate function. All subset frequencies were computed based on the frequencies of individual nonoverlapping Boolean subsets after background subtraction. Responses were considered positive if they were identifiable by at least 1 activation marker, formed a visible cluster on inspection, and included ≥0.01% (1/10 000 T cells) of the reference population. The analysis of target protein recognition profiles and total CMV-specific responses excluded participants whose responses had not been tested with the complete set of 19 peptide pools (eg, for lack of sufficient material).
Absolute T-cell Counts and T-cell Polyfunctionality
Absolute T-cell counts (cells/nL of whole blood) were determined in most, but not all, UK participants. They were computed by multiplying the percentage of CD3 T cells among white blood cells with the white blood cell count obtained with a Sysmex Counter (Sysmex, UK) (see online Supplement for details).
The polyfunctionality index was calculated as previously described [26] (see online Supplement for details).
Statistical Analysis
SPSS v22 software (IBM, London, UK) was used for statistical analyses. The χ 2 test was used to compare protein recognition between cohorts. Histograms, quantile-quantile plots, and the Kolmogorov-Smirnov test were used to determine data distribution. Nonparametric tests (Mann-Whitney) were used to compare groups. T-cell frequencies were log-transformed where appropriate for normalizing distribution or improving data presentation. P values ≤ .05 were considered significant for single endpoints. Multiple endpoint correction (Bonferroni) was applied when appropriate (P ≤ .05/n, where n is the number of endpoints).
RESULTS
T-cell Response Size Is Unrelated to Protein Recognition Frequency
Size and phenotype of T-cell responses to 19 CMV proteins were analyzed in young, older, and oldest old participants (Table 1) . Activated T cells were quantified using 5 simultaneous readouts: IL-2, IFN-γ, TNF, CD107a, and CD154. As previously reported, the average size of the T-cell response to a given CMV protein was unrelated to the proportion of individuals recognizing it ( Figure 1A and 1B) [24] .
CMV-specific T-cell Response Breadth Is Increased in the Oldest Old
Group
The frequencies of T cells recognizing specific target proteins were not significantly different between the young and older groups; however, significant differences existed between the older and oldest old groups with respect to several proteins ( Figure 2A ). The number of target proteins recognized per individual seemed somewhat greater in the older group compared to the young group, but this was not statistically significant. However, the oldest old group had significantly broader responses than the older group ( Figure 2B ). The oldest old group was considered to be examples of exceptional aging and compared only with the older group whose age was within normal expectation (direct comparisons between the oldest old group and the young group did not appear useful).
Median Frequency of CMV-specific TNF-producing CD4 T Cells Is 4.9 Times Higher in Older Than Young Participants
We initially compared responses between the young and older groups, as this was considered to reflect average aging. As a global measure of T-cell responsiveness to CMV (without bias to selected proteins), we first compared the summed response to the 19 proteins ("total response") among CD4 and CD8 T cells, and then the responses to the 2 most frequently recognized proteins for CD4 (UL83, UL55) and CD8 T cells (UL83, UL123) ( Figure 3 ). Response size comparisons were based on the combined readout (cells were considered activated if at least 1 activation marker was positive), IFN-γ alone (the most commonly used T-cell activation marker), or TNF alone. The difference of the total CD4 T-cell response between the young and the older ( Figure 3A ) was statistically significant only when IFN-γ or TNF were considered alone, but not when the combined readout was used. In the older group, the median of the total CD4 T-cell response was 3.2-, 4.5-, and 4.9-fold higher than in the young group for the combined readout, IFN-γ, and TNF, respectively. UL83-specific responses were significantly greater in the older group for each of the readouts, unlike UL55-specific responses, which were not significantly different for any readout. In CD8 T cells, a similar pattern was observed but increases were generally smaller ( Figure 3B ). Medians for the total CD8 T-cell response were 2.1-, 2.3-, and 2.3-fold higher in the older than in the young group for the combined readout, IFN-γ, and TNF, respectively. CD8 T-cell responses to UL83 were also significantly greater in the older group compared with the young group (any readout), but no significant difference was observed with respect to UL123 ("IE-1"). Interestingly, total response size differences (all 19 proteins) between the oldest old group (aged 85-103) and the older group were significant for all readouts for both CD4 and CD8 T cells ( Figure 3A and 3B, left). This might be explained in part by the higher average number of proteins recognized in the oldest old group ( Figure 2B ). For both CD4 and CD8 T cells, UL83-specific responses were also significantly different between these groups for the combined readout and IFN-γ, but not for TNF. The UL55-specific CD4 T-cell response was significantly higher in the oldest old group using the combined readout. No direct comparison between oldest old and young groups was made.
Absolute T-cell Counts May Conceal the Increasing CMV Bias of the T-cell Repertoire in the Older Group
The corresponding response size differences in terms of absolute T-cell counts (cells/nL of blood) between the young and older groups were less conspicuous and statistically significant only for UL83-specific CD4 T cells (Supplementary Figure  S2A and S2B) . At the same time, a general decline of CD4 and, particularly, CD8 T-cell numbers (statistically significant) was observed in the older group (Supplementary Figure S2C and S2D). Therefore, absolute T-cell counts underestimated age-related increases in CMV-specific response dominance that were, however, revealed by the CMV-responsive fractions of CD4 or CD8 T cells ( Figure 3A and 3B). Absolute T-cell counts were not available for the oldest old group.
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CMV-specific CD4 T Cells Arise Predominantly From the Effector Memory
Compartment in Young and Older Groups; From the Central Memory
Compartment in the Oldest Old Group
The distributions of CMV-specific CD4 and CD8 T cells among the memory compartments (defined by CD45RA and CD27 expression) were evaluated in all individuals (CD45RA + /CD27 + = "naive" or T NA ; CD45RA-/CD27 + = "central memory" or T CM ; CD45RA -/CD27 -= "effector memory" or T EM ; CD45RA + / CD27 -= "revertant" or T EMRA ) (Supplementary Figure S3A) . This distribution changes subject to age and CMV status (Supplementary Figure S3B ) [27] , and in CMV + individuals, is also related to the size of CMV-specific T-cell responses [28] . The quantitative contribution of these compartments to the total CMV-specific T-cell response was determined across all 19 target proteins. In the young and older groups, the largest proportion of the CD4 T-cell response arose from the T EM compartment ( Figure 3C ), whereas in CD8 T cells, an equally large or even larger contribution originated from the T EMRA compartment (particularly in the older group) ( Figure 3D) . Surprisingly, in the oldest old group, among CMV-specific CD4 T cells the T CM compartment was dominant ( Figure 3C ). Note that the differences among the sizes of corresponding memory The breadth of the CMV-specific T-cell response is not significantly different between the young and older groups, but strongly increased in the oldest old group. PBMCs from CMV + participants were stimulated overnight with 19 CMV protein-derived overlapping peptide pools. Activated T cells were identified by flow cytometry. A, A comparison of response breadth between the young (white bars) and older (gray bars) groups revealed no significant differences in terms of protein recognition frequencies (CMV proteins are ordered by decreasing frequency of recognition in the older group); however, there were several significant differences between the older and the oldest old groups (dark gray bars) (Bonferroni multiple endpoint correction, significance threshold set to P = .003, significant differences indicated by asterisks). B, The number of recognized CMV target proteins (between 1 and 15) was computed separately for CD4 and CD8 T cells in the young (left), older (middle), and oldest old (right) groups, suggesting a mild (nonsignificant) trend for higher response counts in the older compared to the young groups, but also shows a significant difference between the older and oldest old groups. Cross bars indicate median and interquartile ranges. Abbreviations: CMV, cytomegalovirus; PBMCs, peripheral blood mononuclear cells.
compartments in different age groups in Figure 3C and 3D-for example, the CD4 T CM compartment in the older versus the oldest old groups-reflect the overall response size differences between these age groups and show to what extent these differences are located in each memory compartment. However, relative changes of the contribution that each memory compartment makes to the whole response (ie, all 4 compartments together) are more easily appreciated when the frequencies are normalized, in which case a significant increase is visible for the oldest old group versus the older group in the CD4 T CM compartment, and a significant decrease in the older group compared with the young group in the CD8 T NA compartment (Supplementary Figure S4A) . T-cell memory compartment distributions were also expressed in absolute counts (limited to the young and older groups), showing a very similar pattern as when expressed as fractions of CD4 or CD8 T cells (Supplementary Figure S4B) .
The entire CD4 and CD8 T-cell memory compartments (irrespective of antigen specificity) also showed greater central memory components in the oldest old group than the older group, but differences were not significant. The most striking difference compared with CMV-specific T cells alone was the much smaller relative size of the T EMRA compartment. In the older group, the T EMRA compartment dominated the CD8 T-cell repertoire, whereas in the oldest old group, the T EM compartment was dominant (Supplementary Figure S4C, top and bottom) .
We finally tested T-cell polyfunctionality across the memory compartments; it was generally highest in the T EM compartment in CD4 and CD8 T cells in all 3 groups. However, in the oldest old group, despite a general decline of polyfunctionality the CD8 T NA compartment was more polyfunctional than in the older group (Supplementary Figure 5) . Age-related increases in T-cell response size depend on target protein-specificity and functional response readout. PBMCs from CMV + participants were stimulated overnight with 19 CMV protein-derived overlapping peptide pools. Activated T cells were identified by flow cytometry. While our study focused on "average" aging, (ie, differences between young and older participants, the oldest old group participants are shown as examples of unusually successful aging). A-B, The fractions of all cells displaying at least 1 activation marker ("combined readout"), IFN-γ, or TNF are shown. Diagrams show the CMV-specific T-cell response size (log-transformed fractions of CD4 or CD8 T cells) for all 19 proteins combined (left panels) and the most frequently recognized CMV proteins in the UK cohort for CD4 T cells with respect to UL83 (middle) and UL55 (right) (8), for CD8 T-cells with respect to UL83 (middle) and UL123 (right) (8) . Statistical significance levels are indicated. The main study endpoint was the increase in CMV-specific T-cell response size between the young and older groups (combined readout in connection with all 19 proteins); the significance level of P ≤ .05 was not adjusted. C-D, T-cell memory compartment distributions defined by the expression of CD27 and CD45RA (CD45RA + /CD27 + = "naive" or T NA ; CD45RA -/CD27 + = "central memory" or T CM ; CD45RA -/CD27 -= "effector memory" or T EM ; CD45RA + /CD27 -= "revertant" or T EMRA ) showed significant differences between the young and older groups among CMV-specific T CM CD4 T cells and CD8 revertant (T EMRA ) T cells. Compared with the older group, the oldest old group displayed a striking and significant increase of the CD4 central memory (T CM ) compartment (Mann-Whitney test, significance threshold set to at P ≤ .0125, Bonferroni correction for 4 endpoints). No direct comparison was made between the young and oldest old group participants. Boxplots show minimum, maximum, median, interquartile range, and outliers ("o"). Abbreviations: CMV, cytomegalovirus; IFN-γ, interferon-γ; PBMCs, peripheral blood mononuclear cells; TNF, tumor necrosis factor.
DISCUSSION
Our study explored whether the CMV-specific T-cell response is generally inflated in older people. It provides a more definitive answer than previous work, which has focused on select antigens, individual peptides/major histocompatibility complex multimers, and often single-effector readouts. While CMV-specific T-cell responses were on average larger in older than in young people, our data provide compelling evidence that the size of such differences depends strongly on how the comparison is made: be it with respect to individual proteins or a range of proteins, be it with respect to single activation markers or a combination of activation markers. Response size differences were more pronounced when the analysis was focused on single-effector readouts (IFN-γ, TNF), but less striking when all readouts were considered simultaneously. This demonstrates that the differences in functional profiles among individuals, or groups of individuals, may appear as differences in response size if single activation markers are used as readout.
While 2.1-fold and 3.2-fold higher median frequencies of CMV-specific CD8 and CD4 T cells, respectively, in older compared to young people (considering all T-cell targets and readouts) clearly show a considerable age-related response size increase, it remains unclear if this is enough to significantly undermine immunity in older people. An increase of CMVspecific proinflammatory T cells, however, might have a more profound effect on the immune system. When considering TNF-producing T cells only, the difference between the young group and the older group was "only" 2.3-fold for CD8 T cells but, surprisingly, 4.9-fold for CD4 T cells (a similar pattern was seen for IFN-γ-producing T cells). It appears, therefore, that the effect of aging (within normal bounds) on CMV-specific T-cell numbers has been somewhat overestimated with regard to the CD8 compartment but underestimated with respect to the CD4 compartment. In any case, our work has clarified that a huge increase in TNF-producing CMV-specific T cells does indeed occur in the average CMV+ older person.
Pourgheysari and colleagues [15] , however, previously reported significant expansions of CMV-specific CD4 T cells in older people using a CMV lysate for stimulation. Based on TNF production, they found a little more than a doubling of CMV-specific CD4 T cells in older compared to younger people, which is less than half the difference found in the present study. This discrepancy could first be explained by the fact that the "young" people examined by Pourgheysari were up to 50 years old compared with up to 35 years in our study; and second, that CMV lysate (made from CMV-infected fibroblasts) does not stimulate T cells as effectively as protein-spanning peptide pools [24] .
The oldest old participants represented a group of exceptional, successfully aged people. They recognized more proteins on average than the older group (see Figure 2B ) and their summed responses to all proteins were much greater, irrespective of readout. Future research will determine whether increased response breadth contributes to successful aging, is a by-product of it, or is possibly the result of lifestyle factors that contribute to longevity. Interestingly, the role of UL83 as an unusual protein with regard to driving CMV-specific T-cell expansions was confirmed by the observation of an even greater difference in response size between the oldest old group and older group than between the older group and young group. Whether very large UL83-specific T-cell responses are harmful, helpful, or maybe neither, remains unclear. Unlike the young and older groups who were predominantly white and British, participants in the oldest old group were white and Italian. Both population samples belong to the same major ethnicity (Caucasoid); however, the frequencies of some human leukocyte antigen (HLA) alleles vary between UK and Italian populations according to the online Allele Frequency Net Database (www.allelefrequencies.net) [29] . It may be that HLA type or other genetic factors have affected the response breadth and/or size somewhat, but it is very unlikely these factors alone would explain the full extent of the differences we have observed.
By quantifying the contribution of the different T-cell memory compartments to the overall CMV-specific response in a summative way across all 19 target proteins, our study significantly extends research from previous reports [10, 28, 30] . This comprehensive evaluation demonstrated that in both young and older participants, the bulk of the CMV-specific T-cell response arises from the T EM compartment in CD4 T cells and, to a similar extent, from the T EM and T EMRA compartments in CD8 T cells. In the oldest old group ("survivors"), however, a large contribution to the CD8 T-cell response size and the greatest contribution to the CD4 T-cell response size originated from the T CM compartment. This raises the question, does an increase of this compartment occur as a result of successful aging or is it a survival advantage during the process of aging? The latter would support the idea that a long-lived T CM pool provides improved protection from infection as a result of its ability to proliferate upon antigen re-exposure [31] .
Interestingly, it was recently shown that the live attenuated varicella-zoster virus vaccine Zostavax boosts polyfunctional central memory CD4 T cells in individuals aged 55-65 [32] . It is, therefore, tempting to speculate that the expansion of the T CM compartment-in terms of CMV-specific T-cells and in general-reflects natural boosting by exposure to real infections. However, this observation and the potential consequences for vaccine design would need to be assessed in future studies.
Importantly, the definition of T-cell memory compartments by CD45RA versus CD27 expression is not precise; for example, T cells in the naive compartment would not be expected to produce IFN-γ after overnight stimulation, indicating a more advanced phenotype. Nonetheless, these and similar subset definitions based on 2 markers (eg, CD45RA and CCR7) provide good overall subset discrimination and are widely used in the field [28, 33] . Interestingly, stem cell memory T cells (T SCM ) are antigen-experienced and, like naive cells, express CD45RA and CD27. It is possible, therefore, that the oldest old group participants have accumulated CMV-specific T SCM [34] , potentially contributing to protection.
Using the same cohorts, we recently reported that polyfunctionality was, on the whole, reduced in the oldest old group [35] ; however, we did not examine differences between T-cell memory subsets. Our current analysis confirmed that polyfunctionality in the oldest old group is generally lower than in the older individuals, but it also showed a slight increase of polyfunctionality in CD8 T NA cells. This agrees with a recent report by others showing increased polyfunctionality among CD8 T NA (but interestingly, not T SCM ) cells in an older compared to a younger participant group [36] . Age-wise, this older group was in between our older and oldest old groups.
Importantly, our present work shows that age-related expansions of the CMV-specific T-cell response can only be fully appreciated if a representative range of proteins and several functional readouts are considered in combination, allowing an assessment of response breadth with regard to both target proteins and functionality. We also previously demonstrated striking differences between individuals regarding CMV protein dominance and response hierarchies [37] , providing an additional reason to use many target proteins in parallel for this type of work. In conclusion, our current and previous findings combined suggest that a possible "signature" of successful aging might include a broad CMV-specific T-cell response with a large central memory component but overall moderate polyfunctionality (thus, avoiding unnecessary "collateral" tissue damage) [35] . We believe that our work will be useful in informing the design of future studies in this field.
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